| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | 0.073 | 0.03 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | 0.072 | 0.03 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.03 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.067 | 0.03 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.062 | 0.03 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.03 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.04 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.071 | 0.04 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.04 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.04 |